Bollard Group LLC Abeona Therapeutics Inc. Call Options Transaction History
Bollard Group LLC
- $4.37 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ABEO
# of Institutions
101Shares Held
31.4MCall Options Held
2.42MPut Options Held
212K-
Nantahala Capital Management, LLC New Canaan, CT4.37MShares$19.9 Million1.08% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.07MShares$14 Million0.03% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.68MShares$12.2 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$11.4 Million0.0% of portfolio
-
Western Standard LLC Los Angeles, CA2.09MShares$9.54 Million6.61% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $27.1M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...